Optical Genome Mapping in Hematological Malignancies
Recruiting
Observational Study
MDS
ALL
Other Hematologic Malignant Neoplasms
No Study Drug
Researchers observe your health over time — no experimental treatment is given.
At a Glance
- Sex
- Any
- Study type
- Observational
- Participants needed
- 200 (estimated)
- Sponsor
- University Hospital, Brest · Other
Think this trial could be right for you?
Answer a few quick questions to see if you may meet the eligibility requirements.
Check Your Eligibility
About This Trial
Establish the diagnostic potential of optical genome mapping in patients with suspected hematologic cancer
Trial Locations
Loading…
Loading trial locations…
Eligibility Criteria
Inclusion Criteria:
* Minor/Major Patients
* Patients with suspected hemopathies for whom we receive a sample for diagnosis in the chromosomal genetics laboratory or for whom a diagnosis of hemopathy has already been made.
* No objection made or consent given
Exclusion Criteria:
* Patients under …
Contacts